Recurrence risk of node-negative and ER-positive early-stage breast cancer patients by combining recurrence score, pathologic, and clinical information: A meta-analysis approach

被引：0
|
作者：
Tang, G.
Cuzick, J.
Wale, C.
Costantino, J. P.
Crager, M.
Shak, S.
Wolmark, N.
Dowsett, M.
Forbes, J. F.
机构：
[1] Natl Surg Adjuvant Breast & Bowel Project, Pittsburgh, PA USA
[2] Univ London, London, England
[3] Genom Hlth, Redwood City, CA USA
[4] Natl Surg Adjuvant Breast & Bowel Project & Alleg, Pittsburgh, PA USA
[5] Royal Marsden Hosp, London SW3 6JJ, England
[6] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
509
引用
收藏
页数：1
相关论文
共 50 条
  • [41] 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer
    Gulisa Turashvili
    Joanne F. Chou
    Edi Brogi
    Monica Morrow
    Maura Dickler
    Larry Norton
    Clifford Hudis
    Hannah Y. Wen
    Breast Cancer Research and Treatment, 2017, 166 : 69 - 76
  • [42] 21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer
    Turashvili, Gulisa
    Chou, Joanne F.
    Brogi, Edi
    Morrow, Monica
    Dickler, Maura
    Norton, Larry
    Hudis, Clifford
    Wen, Hannah Y.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (01) : 69 - 76
  • [43] Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer
    Lee, Su Hyun
    Ha, Seunggyun
    An, Hyun Joon
    Lee, Jae Sung
    Han, Wonshik
    Im, Seock-Ah
    Ryu, Han Suk
    Kim, Won Hwa
    Chang, Jung Min
    Cho, Nariya
    Moon, Woo Kyung
    Cheon, Gi Jeong
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (09) : 1574 - 1584
  • [44] Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer
    Su Hyun Lee
    Seunggyun Ha
    Hyun Joon An
    Jae Sung Lee
    Wonshik Han
    Seock-Ah Im
    Han Suk Ryu
    Won Hwa Kim
    Jung Min Chang
    Nariya Cho
    Woo Kyung Moon
    Gi Jeong Cheon
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1574 - 1584
  • [45] RECURRENCE RATES IN NODE-NEGATIVE PATIENTS AFTER SENTINEL NODE BIOPSY FOR EARLY-STAGE VULVA CANCER - A NATIONAL PROSPECTIVE STUDY
    Froding, L. Paskeviciute
    Hogdall, C.
    Zobbe, V.
    Ortoft, G.
    Mathiesen, O.
    Niemann, I.
    Schnack, T. Henrichsen
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 28 - 28
  • [46] Recurrence patterns following a negative sentinel lymph node biopsy in patients with early-stage breast cancer
    Taback, B
    Hansen, N
    Conway, K
    Giuliano, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 17S - 17S
  • [47] Risk of Recurrence in Early-Stage, HER2-Positive Breast Cancer
    Isaacs, Claudine
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (08) : 3 - 6
  • [48] 21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy
    Mamounas, Eleftherios P.
    Liu, Qing
    Paik, Soonmyung
    Baehner, Frederick L.
    Tang, Gong
    Jeong, Jong-Hyeon
    Kim, S. Rim
    Butler, Steven M.
    Jamshidian, Farid
    Cherbavaz, Diana B.
    Sing, Amy P.
    Shak, Steven
    Julian, Thomas B.
    Lembersky, Barry C.
    Wickerham, D. Lawrence
    Costantino, Joseph P.
    Wolmark, Norman
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (04):
  • [49] META-ANALYSIS OF PROSPECTIVE EUROPEAN STUDIES ASSESSING THE IMPACT OF USING THE 21-GENE RECURRENCE SCORE ASSAY ON CLINICAL DECISION MAKING IN WOMEN WITH ER-POSITIVE, HER2-NEGATIVE EARLY STAGE BREAST CANCER
    Albanell, J.
    Holt, S.
    Gligorov, J.
    Eiermann, W.
    Svedman, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 97 - 97
  • [50] A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores
    Takeo Fujii
    Hiroko Masuda
    Yee Chung Cheng
    Fei Yang
    Aysegul A. Sahin
    Yasuto Naoi
    Yuki Matsunaga
    Akshara Raghavendra
    Arup Kumar Sinha
    Jose Rodrigo Espinosa Fernandez
    Anjali James
    Keisuke Yamagishi
    Tomoko Matsushima
    Robert Schuetz
    Debu Tripathy
    Sachiyo Tada
    Rubie S. Jackson
    Shinzaburo Noguchi
    Seigo Nakamura
    Jared D. Acoba
    Naoto T. Ueno
    Breast Cancer Research and Treatment, 2021, 189 : 455 - 461
12345